Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano-X Imaging (NNOX) Non-cash Items (2019 - 2025)

Nano-X Imaging posted quarterly Non-cash Items of $3.6 million for Q4 2025, up 7.97% year-on-year from $3.4 million in Q4 2024, and up 7.97% on a QoQ basis from $3.4 million in Q4 2024.

Nano-X Imaging (NNOX) has 7 years of Non-cash Items data on file, last reported at $3.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 7.97% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $3.6 million (up 7.97% YoY), and the FY2025 full-year result was $3.6 million, up 7.97% from the prior year.
  • Non-cash Items for Q4 2025 stood at $3.6 million, up from $3.4 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.6 million in Q4 2025 and bottomed at $1.4 million in Q4 2022.
  • The 5-year median for Non-cash Items is $3.4 million (2024), against an average of $2.7 million.
  • The widest annual swing landed in 2021, when Non-cash Items declined 26.12%; it then surged 165.38% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $1.6 million in 2021, then dropped by 15.69% to $1.4 million in 2022, then soared by 165.38% to $3.6 million in 2023, then slipped by 7.09% to $3.4 million in 2024, then climbed by 7.97% to $3.6 million in 2025.
  • The last three Non-cash Items figures came in at $3.6 million (Q4 2025), $3.4 million (Q4 2024), and $3.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Nano-X Imaging 126,664.45 -59.48 Mn -3.62 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.63 Mn
Dec 31, 2025 3.63 Mn
Dec 31, 2024 3.37 Mn
Dec 31, 2024 3.37 Mn
Dec 31, 2023 3.62 Mn
Dec 31, 2023 3.62 Mn
Dec 31, 2022 1.36 Mn
Dec 31, 2022 1.36 Mn
Dec 31, 2021 1.62 Mn
Dec 31, 2021 1.62 Mn
Dec 31, 2020 2.19 Mn
Dec 31, 2020 2.19 Mn
Dec 31, 2019 1.83 Mn
Dec 31, 2019 1.83 Mn